EQUITY - Narrative (Details) - USD ($) shares in Thousands, $ in Millions |
9 Months Ended | |||
|---|---|---|---|---|
Jun. 27, 2026 |
Jun. 28, 2025 |
Jan. 26, 2026 |
Dec. 19, 2025 |
|
| Schedule of Equity Method Investments [Line Items] | ||||
| Share repurchase program, authorized amount | $ 500.0 | |||
| Number of shares authorized (in shares) | 2,750 | |||
| Cash received from exercise of stock options | $ 3.9 | $ 11.2 | ||
| Restricted Stock Units (RSUs) | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Unrecognized pre-tax compensation cost | 4.8 | |||
| Accrued award liability | $ 12.0 | |||
| X | ||||||||||
- Definition Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements payable within one year (or the operating cycle, if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash inflow from exercise of option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|